Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWolf Minerals Regulatory News (WLFE)

  • There is currently no data for WLFE

Commissioning Complete at Hemerdon Project

23 Sep 2015 07:00

RNS Number : 8848Z
Wolf Minerals Limited
23 September 2015
 



 

23 September 2015

 

Wolf Minerals Limited

 

Commissioning Complete at Hemerdon Tungsten and Tin Project

 

Highlights

· Commissioning of the processing plant at Drakelands mine has been completed.

· Wolf now in full operational control of processing plant following handover from GR Engineering Services.

· First shipment of concentrate dispatched from Drakelands for delivery to customers.

Specialty metals development company, Wolf Minerals Limited (ASX: WLF, AIM: WLFE) ("Wolf" or "the Company") is pleased to announce the completion of commissioning of the processing plant at the Drakelands open pit mine ("Drakelands") constructed at the Company's world class Hemerdon tungsten and tin project ("the Project") in Devon, southwest England.

 

Construction of the processing plant started on site in March 2014 and wet commissioning of the plant commenced in June 2015. The entire processing plant, and all the equipment within it, has now run successfully satisfying the requirements for handover to Wolf. As a result of this success, Wolf has taken full operational control of the plant from the project's EPC contractor, GR Engineering Services.

 

The inaugural shipment of tungsten concentrate has also been dispatched from Drakelands for delivery to a long term customer, marking the Company's first generation of revenue and operating cash flow.

 

Wolf Managing Director, Russell Clark, commented:

 

"The conclusion of commissioning activities represents another major milestone in the development of the Project, and I congratulate the Wolf team, GR Engineering Services and their sub-contractors, who have worked together to safely achieve this landmark." 

 

"With the inaugural shipment, Wolf has now realised its ambition of becoming a tungsten producer and we expect to supply high quality concentrate to our customers for many years into the future."

 

Following completion of commissioning, the Company has commenced the 'ramp-up' of the processing plant towards full production. Design throughput of the plant is expected to be achieved in early 2016.

 

The Drakelands mine and processing plant are now operating on a seven days a week basis under a six month trial which will run through to February 2016. If the trial is successful Wolf will apply to make the arrangement permanent. A permanent change would increase available operating time by more than 27% in comparison to the original permission for a 5½ day working week and provide the opportunity to produce additional volumes of tungsten and tin concentrates with no further capital expenditure. It also provides the opportunity to lower operating costs, pushing the operation further down the tungsten concentrate production cost curve as well as generate additional employment opportunities.

 

ENDS

Wolf Minerals Limited

Russell Clark

+61 8 6364 3776

Numis Securities

John Prior/James Black/Paul Gillam

+44(0)20 7260 1000

 

Newgate

Tim Thompson / Adam Lloyd / Ed Treadwell / Helena Bogle

+44 (0) 20 7653 9840

 

 

About Wolf Minerals

Wolf Minerals is a dual listed ("ASX: WLF", "AIM: WLFE") specialty metals company. With global demand for tungsten rising and future global production expected to be constrained, Wolf Minerals has recently completed the development of a large tungsten resource at its Drakelands Mine, located at Hemerdon, in southwest England.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAANAAFXSEAF
Date   Source Headline
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:01 amRNSAppendix 3Y
30th Jun 20177:01 amRNSIssue of Equity and Change of Directors' Interests
29th Jun 20179:15 amRNSReplacement of Grant of ASX Listing Rule Waivers
28th Jun 20173:15 pmRNSASX Listing Waivers for Bridge Facility Increase
28th Jun 20173:15 pmRNSBridge Facility with RCF Increased
16th Jun 20177:00 amRNSIssue of Equity
16th Jun 20177:00 amRNSAppendix 3B
16th May 20177:00 amRNSCancellation of Lapsed Performance Rights
15th May 20179:05 amRNSAppendix 3Z
15th May 20179:05 amRNSResignation of Director
8th May 20177:00 amRNSAppendix 3X
8th May 20177:00 amRNSInterim MD, Richard Lucas, Appointed to Wolf Board
28th Apr 20177:00 amRNSAppendix 5B
28th Apr 20177:00 amRNSQuarterly Activities Report
7th Apr 201710:19 amRNSDirectorate Change
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSIssue of Equity and Change of Directors' Interests
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSCleansing Notice Letter
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3B
4th Apr 20177:00 amRNSAppendix 3Y
16th Mar 20177:02 amRNSInterim Financial Statements
13th Mar 20177:35 amRNSUpdate on Bridge Facility with RCF
20th Feb 20174:41 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
10th Feb 20179:20 amRNSCancellation of Lapsed Performance Rights
6th Feb 20177:00 amRNSRevised Securities Dealing Policy
31st Jan 20177:00 amRNSAppendix 5B
31st Jan 20177:00 amRNSQuarterly Activities Report
30th Dec 20168:10 amRNSCleansing Notice Letter
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3B
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:09 amRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20161:15 pmRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.